Found: 32
Select item for more details and to access through your institution.
Methylnaltrexone.
- Published in:
- Oncologist, 2009, v. 14, n. 7, p. 679, doi. 10.1634/theoncologist.2009-0049
- By:
- Publication type:
- Article
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of <sup>177</sup>Lu‐PSMA‐617 in prostate cancer patients.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 8, p. 1060, doi. 10.1002/psp4.12914
- By:
- Publication type:
- Article
The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel.
- Published in:
- Journal of Pharmacy & Pharmacology, 2014, v. 66, n. 6, p. 865, doi. 10.1111/jphp.12208
- By:
- Publication type:
- Article
A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute.
- Published in:
- International Journal of Clinical Pharmacy, 2021, v. 43, n. 1, p. 181, doi. 10.1007/s11096-020-01131-z
- By:
- Publication type:
- Article
Follow up survey for implementation of fixed-dosing of monoclonal antibodies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course.
- Published in:
- PLoS ONE, 2021, v. 16, n. 11, p. 1, doi. 10.1371/journal.pone.0260073
- By:
- Publication type:
- Article
Automated radiolabelling of [<sup>68</sup>Ga]Ga-PSMA-11 (gallium (<sup>68</sup>Ga)-gozetotide) using the Locametz® kit and two generators.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00260-4
- By:
- Publication type:
- Article
Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [<sup>177</sup>Lu]Lu-PSMA.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2022, v. 7, n. 1, p. 1, doi. 10.1186/s41181-022-00181-0
- By:
- Publication type:
- Article
Quality control of [<sup>177</sup>Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2022, v. 7, n. 1, p. 1, doi. 10.1186/s41181-022-00178-9
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00146-9
- By:
- Publication type:
- Article
Severe Lactic Acidosis in a Diabetic Patient after Ethanol Abuse and Floor Cleaner Intake.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2014, v. 115, n. 5, p. 472, doi. 10.1111/bcpt.12251
- By:
- Publication type:
- Article
Robotgeassisteerde PSMA-radiogeleide chirurgie bij recidiverend prostaatkanker met de DROP-IN-gammaprobe: Het eerste prospectieve haalbaarheidsonderzoek.
- Published in:
- Tijdschrift voor Urologie, 2023, v. 13, n. 1, p. 11, doi. 10.1007/s13629-022-00375-w
- By:
- Publication type:
- Article
The effect of long-acting somatostatin analogues on the uptake of [<sup>177</sup>Lu]Lu-HA-DOTATATE.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1434, doi. 10.1007/s00259-022-06094-z
- By:
- Publication type:
- Article
Predicting the effect of different folate doses on [<sup>68</sup>Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-01008-y
- By:
- Publication type:
- Article
A physiologically based pharmacokinetic model for [<sup>68</sup>Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-00958-7
- By:
- Publication type:
- Article
Somatostatin receptor saturation after administration of high peptide amounts of [<sup>177</sup>Lu]Lu-HA-DOTATATE: when enough is enough.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00946-3
- By:
- Publication type:
- Article
Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review.
- Published in:
- Theranostics, 2022, v. 12, n. 18, p. 7804, doi. 10.7150/thno.77279
- By:
- Publication type:
- Article
Combined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS.
- Published in:
- Biomedical Chromatography, 2014, v. 28, n. 2, p. 302, doi. 10.1002/bmc.3021
- By:
- Publication type:
- Article
Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Quantification of biochemical PSA dynamics after radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model.
- Published in:
- EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00642-2
- By:
- Publication type:
- Article
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology.
- Published in:
- Pharmacology Research & Perspectives, 2021, v. 9, n. 2, p. 1, doi. 10.1002/prp2.757
- By:
- Publication type:
- Article
No relation between docetaxel administration route and high‐grade diarrhea incidence.
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 4, p. 1, doi. 10.1002/prp2.633
- By:
- Publication type:
- Article
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 5, p. 779, doi. 10.1007/s11523-024-01087-4
- By:
- Publication type:
- Article
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 5, p. 789, doi. 10.1007/s11523-024-01075-8
- By:
- Publication type:
- Article
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 3, p. 441, doi. 10.1007/s11523-023-00958-6
- By:
- Publication type:
- Article
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on <sup>68</sup>Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 63, doi. 10.2967/jnumed.122.264101
- By:
- Publication type:
- Article
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68GaPSMA-11 PET/CT in Primary Prostate Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264101
- By:
- Publication type:
- Article
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on <sup>68</sup>Ga-PSMA-11 PET/CT in Primary Prostate Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264101
- By:
- Publication type:
- Article
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on <sup>68</sup>Ga2 PSMA-11 PET/CT in Primary Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264101
- By:
- Publication type:
- Article
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on <sup>68</sup>Ga-PSMA-11 PET/CT in Primary Prostate Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264101
- By:
- Publication type:
- Article
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow).
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2020, v. 5, n. 1, p. 1, doi. 10.1186/s41181-020-00095-9
- By:
- Publication type:
- Article
Predicting [<sup>177</sup>Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [<sup>68</sup>Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling.
- Published in:
- EJNMMI Physics, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s40658-023-00565-4
- By:
- Publication type:
- Article